St. Kitts
and Nevis (WINN): A week after
controversy erupted over a regenerative medicine project at the JNF hospital,
there are still unanswered questions about whether there was a breach of
protocol in setting up the initiative, and who is running the show.
What is
clear a week later however is that legislation governing experimental research
therapy such as the one being conducted at the JNF is not yet in place; the
government has acknowledged this, and has indicated that it is being prepared.
Another
debate that has raged all week about whether the research is a stem cell
project seems to be somewhat reluctantly settled.
Despite
initial efforts to suggest otherwise and label it otherwise, it has been
confirmed that the research, while it reportedly does not involve the
introduction of stem cells into the patient, is designed to stimulate stem cell
growth.
Retiring
Chief Medical Officer Dr. Patrick Martin has come in for heavy fire from the
Junior Minister of Health and the Prime Minister for referring to the project
as a stem cell initiative. Initially the
Junior Minister of Health Senator Wendy Phipps vehemently denied that the
research was a stem cell project.
“As
Minister of State with Responsibility for Health I wish to state categorically
that neither the Ministry of Health nor the JNF General Hospital is engaged in
any stem cell project…it is extremely unfortunate that Dr. Martin has sought to
link his retirement to alleged stem cell research when he knows that there is
no stem cell research currently occurring in the Federation.”
In a
statement issued Wednesday, St. Kitts Biomedical President Dr. Eugene Redmond
backed the government’s claim, categorically dismissing the charge that the JNF
project employs the use of stem cells.
“This
treatment did not involve stem cells whatsoever. The fact that it has become a stem cell
controversy is…based on total misinformation,” he said in the statement.
According
to Dr. Redmond, the experimental treatment involves the intravenous injection
of a small amount of plasma, a component of blood from which all cells have
been removed.
However,
scientists and a medical expert have explained to WINN FM that umbilical cord
plasma has growth factors that stimulate a body’s stem cells to grow, divide
and repair.
So while
the plasma being used in the JNF project may not contain stem cells, it is
being used to stimulate their production.
The
Junior Minister acknowledged this when asked at a press conference to explain
the difference between regenerative research and stem cell research.
“The
other side of the equation under regenerative medicine is that of cord blood
plasma type therapies which are platelet infused - and that type of therapy of
the like being done at the JNF - is done by [an] IV treatment, and what the
scientist is in fact trying to do is to encourage the human body into creating
its own stem cell for regenerative purposes, for example, the repair of damaged
tissue and organs.”
The
project came to the public’s attention just over a week ago, when the retiring
CMO charged that his abrupt retirement was triggered by his objection to the
way the project had been set up.
The
government has rubbished his claims, charging that Dr. Martin – how three years
past retirement age - was well aware that his retirement was pending.
The
government meanwhile – despite Dr. Martin’s claims otherwise, has insisted that
there was no breach of the Public Health Act in the establishment of the
project in a section of the private ward at the JNF Hospital.
The
Junior Minister of Health says advice was sought on the project and a second
generative medicine project that it has been approved, from a number of other
sources, including members of the Medical Board and PAHO.
St. Kitts
Biomedical’s Dr. Redmond too, has indicated that he has sought advice from a
panel of experts in helping to assist with the establishment of the project.
But Dr.
Martin – who has emphasized that he has no issue with stem cell research in
principle - continues to maintain that proper procedure was not followed.
“We have
a law, the Public Health Act which empowers the Ministers and CMO, the Chief
Medical Officer to do certain things in relation to safeguarding the nation’s
health. One of those things has to do
with the monitoring, vetting of research activities.”
In a
statement issued to the media on Thursday he quotes sections of the Public
Health and Medical Acts, that he interprets identify the office of the CMO as
the proper authority to advise on projects such as the one underway at the JNF,
including the use and importation of products like blood plasma.
He has
also raised the as yet unanswered question of who is in charge of the project.
Dr.
Martin in his statement Thursday indicated that he has received a document
entitled “Infusion Protocol for Human Umbilical Cord Blood Plasma.”
The
document - which WINN FM has also received a copy of - speaks to a JNF
Regenerative Medicine/Stem Cell activity.
Dr.
Martin continues to question the involvement of controversial billionaire Peter
Nygard in the project. The government
has categorically denied that Mr. Nygard is directly involved but the protocols
that speak to Human Umbilical Cord Blood Plasma have the word “Nygard” printed
on the cover page.
WINN FM
understands that Mr. Nygard has reportedly been seen on the JNF premises.
The
Medical Chief of Staff at the JNF Dr. Cameron Wilkinson, who is now also the
Acting Chief Medical Officer, has made reference to a stem cell project that
received generous support when it was proposed over a year ago, but he said
that it did not come to fruition.
It is not
clear if the Nygard protocols that have now surfaced are those of that
abandoned project, but what is clear is that they are also those of a Human
Umbilical Cord Blood Plasma infusion project.
The
Nygard document lists the Responsible Party as the Frigate-Bay based, Advanced
Institute of Regenerative Medicine, and the Principal Doctor is identified as
S. Lagrotta MD, the same Dr. Lagrotta who is working on the identically named
research underway at the JNF.
The
government has acknowledged that Dr. Lagrotta is not registered and not
licensed to practice in the Federation.
It insists that she has observer status only and that the process of her
certification and licensing has been initiated.
“A
Brazilian expert, Dr. Silvia Lagrotta, who is attached to the project does not
and has not ever administered any therapies to any patients in St. Kitts and
Nevis. Her presence thus far has been
strictly limited to observing the process as a representative of the investor
group’s Brazilian partner. In
anticipation that Dry Lagrotta will be professionally engaged during the life
of this project, her medical credentials have been submitted in the normal
course for approval to function within the Federation as a medical practitioner
consistent with the laws and regulations of the Federation,” Senator Phipps
said in a public statement.
The
Senator has advised that the therapies are being administered by two staff
nurses at the Hospital, with pro bono volunteer oversight by Dr. Dwain
Archibald (a staff doctor) and further oversight by the JNF’s Medical Chief of
Staff - now also appointed Acting CMO - Dr. Wilkinson, along with the Director
of Institutional-based Nursing Services Matron Sonia Daley-Findlay.
Retiring
CMO Dr. Martin however, says that when he approached Dr. Lagrotta at the JNF on
June 13th she appeared to be ‘on the job.’
“There
was a Brazilian doctor there who was practicing without registration or
license. How do I know that? She was identified to me by Dr. Archibald and
she had a stethoscope around her neck - that is Dr. Archibald who was
identified in the Minister’s…speech. The
Brazilian doctor had a stethoscope around her neck and she had gloves on. I shook her hand, after she took off the
gloves of course, and told her that she was practicing in violation of the
Medical Act and that she should cease, desist and leave the premises,” Dr.
Martin told WINN.
There has
been no clarification of that claim on the part of the government and no clear
statement on who is in charge of the JNF research therapy.
Meantime,
St. Kitts Biomedical’s Dr. Redmond, who does work in stem cell research, has
ruled himself out as overseeing the JNF initiative.
In his
statement this week, he made it clear that neither he nor his Foundation is
participants in the project. He says
they have provided advice to ensure that any experimental treatments are done
according to the most rigorous international standards.
His
statement did seem to contradict that of the Dr. Wilkinson who said this week
that Redmond ‘spearheads’ the project.
Contacted
for clarification on Friday Dr. Redmond told WINN FM he could appreciate that
Dr. Wilkinson used the term spearheading to describe his role, but he insisted
that it was purely advisory. He
reiterated that he was not a participant and was seeking only to ensure that
the group had covered all the bases in establishing the project.
He said
he was determined that he was not going to be directly involved in the project,
but was concerned because there are a lot of disreputable medical tourism
projects going on in the Caribbean and other places around the world.
He told
WINN that that he wanted to do what he would could with his connections in the
scientific community to try to help St. Kitts do something that was safe and
reputable.
Dr.
Redmond emphasized that he supports the recommendation from a panel of
scientific experts that he assembled in St. Kitts last year, that legislation
should be passed to establish a “Medical ethics and scientific review board.”
Such a body he said would consist of local and international experts to
evaluate and recommend the approval or rejection of any new therapies that are
proposed for the Federation by any party in the future.
In
summary, a week later it has been established that the project involves the
stimulation of stem cells to encourage their regeneration, and that legislation
has yet to be passed to govern such research.
It is not
clear however, whether Peter Nygard - an advocate of stem cell technology to
reverse the afflictions of aging and the founder of the Bahamas-based Nygard
Biotech – is in some way involved or associated with the current project at
JNF. It is also not clear who is in
charge of the project as Dr. Lagrotta awaits appropriate licensing and is
according to the government, an observer.
Other as
yet unanswered questions raised this past week by the retiring CMO Dr. Martin
include how the blood plasma is being brought into the country, why relevant US
FDA registry has returned no results for the phrase “Human Umbilical Cord Blood
Plasma Phase 1” undertaken by the party named in the protocol document and
whether a US FDA approval is license to conduct research in the sovereign state
of St. Kitts and Nevis.
WINN FM
continues to follow this developing story.
Photo (left to right): Medical Chief of Staff
at the JNF Hospital and Acting CMO Dr. Cameron Wilkinson, President St. Kitts
Biomedical Research Foundation Dr. Eugene Redmond, Retiring CMO and President
of the St. Kitts and Nevis Medical Board Dr. Patrick Martin, Junior Minister of
Health Senator Wendy Phipps
Toni
Frederick
No comments:
Post a Comment